Founded in Kirkland, United States, Cardiac Dimensions is dedicated to developing innovative medical devices aimed at treating heart failure and mitral valve regurgitation. The company's core mission is to improve the quality of life for patients suffering from these conditions through advanced interventional tools. Their flagship product, the Carillon Mitral Contour System, is designed to provide a minimally invasive solution for mitral valve repair, targeting a global market of healthcare providers and patients.
Cardiac Dimensions has garnered support from notable investors and medical professionals, contributing to its reputation in the medtech industry. The company has achieved significant milestones, including successful clinical trials and regulatory approvals in various regions. Its impact is evident in the enhanced treatment options available for heart failure patients, positioning Cardiac Dimensions as a leader in cardiac care innovation.
